Home > Riviste > European Journal of Physical and Rehabilitation Medicine > Fascicoli precedenti > European Journal of Physical and Rehabilitation Medicine 2019 February;55(1) > European Journal of Physical and Rehabilitation Medicine 2019 February;55(1):56-62

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   Freefree

European Journal of Physical and Rehabilitation Medicine 2019 February;55(1):56-62

DOI: 10.23736/S1973-9087.18.05191-2

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Classes of vitamin D status and functional outcome after hip fracture: a prospective, short-term study of 1350 inpatients

Marco DI MONACO 1 , Carlotta CASTIGLIONI 1, Silvia DI CARLO 1, Elena LA MARMORA 2, Irena FILIPOVIC 2, Edoardo MILANO 1, Marco A. MINETTO 2, Giuseppe MASSAZZA 2

1 Division of Physical Medicine and Rehabilitation, Osteoporosis Research Center, Presidio Sanitario San Camillo, Opera San Camillo Foundation, Turin, Italy; 2 Division of Physical Medicine and Rehabilitation, Department of Surgical Sciences, University of Turin, Turin, Italy



BACKGROUND: Vitamin D depletion is associated with unfavourable outcomes after hip fracture. However, the classes of vitamin D status currently in use, which are defined according to serum calcifediol levels, have not been validated for their predictive capability of the functional recovery.
AIM: To investigate the association between serum calcifediol categorized into 4 classes and the functional recovery after hip fracture.
DESIGN: Prospective, short-term observational study.
SETTING: Rehabilitation hospital in Italy.
POPULATION: We evaluated 1350 of 1412 inpatients with hip fracture.
METHODS: Serum calcifediol was measured by an immunoenzymatic assay 14.7±4.4 (mean±SD) days after surgery and categorized into 4 classes: I class <12 ng/mL; II class 12-20 ng/mL; III class 21-29 ng/mL; IV class ≥30ng/mL. The functional outcome was assessed by using the Barthel Index.
RESULTS: We found a significant difference in Barthel index scores at the end of inpatient rehabilitation across the 4 classes of vitamin D status: χ2 (3, N.=1350) 27.2; P<0.001. The difference persisted after adjustment for 8 covariates (P=0.004). By comparing pairs of classes, we found that Barthel index scores were lower in the 829 patients of the I class than in the 275 of the II (P=0.005) who had in turn Barthel index scores lower than the 132 patients of the III class (P=0.038). Conversely, no significant differences emerged between the patients of the III class and the 114 patients of the IV class (P=0.421). The results did not materially change when Barthel Index effectiveness was substituted for Barthel Index scores as the outcome measure.
CONCLUSIONS: Calcifediol levels below 12ng/mL were associated with a worse recovery than those between 12 and 20ng/mL that were in turn associated with a worse recovery than those between 21 and 29 ng/mL. Conversely, no significant differences were found between the patients with calcifediol between 21 and 29ng/mL and those with calcifediol ≥30 ng/mL.
CLINICAL REHABILITATION IMPACT: Despite caution due to the observational design, our study suggests that vitamin D depletion should be treated after hip fracture to optimize the functional outcome, with a target level for serum calcifediol of 21-29ng/mL and no further advantages associated with calcifediol levels of 30ng/mL or higher.


KEY WORDS: Hip fractures - Rehabilitation - Vitamin D

inizio pagina